Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 2, 2014Therapeutic Advances in PsychopharmacologyOpen Access

The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSofia BrissosPsychiatric Medical CenterMRMiguel Ruíz-VeguillaInstituto de Biomedicina de SevillaDTDavid TaylorNorthern Illinois University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brissos et al. (2014) studied this question.

synapsesocial.com/papers/6a10b9b8326831f8a2644beehttps://doi.org/10.1177/2045125314540297
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of Violence With Emergence of Persecutory Delusions in Untreated Schizophrenia2013 · 196 citations
  2. 2Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention2010 · 91 citations
  3. 3Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia2012 · 22 citations
  4. 4Why aren't depot antipsychotics prescribed more often and what can be done about it?2005 · 109 citations